Published in Biomaterials on March 03, 2007
A silver ion-doped calcium phosphate-based ceramic nanopowder-coated prosthesis increased infection resistance. Clin Orthop Relat Res (2013) 0.98
The use of BMP-2 coupled - Nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects. Biomaterials (2010) 0.96
The role of microbial biofilms in prosthetic joint infections. Acta Orthop (2014) 0.95
Mechanical, in vitro antimicrobial, and biological properties of plasma-sprayed silver-doped hydroxyapatite coating. ACS Appl Mater Interfaces (2012) 0.93
Measurement of the silver ion concentration in wound fluids after implantation of silver-coated megaprostheses: correlation with the clinical outcome. Biomed Res Int (2013) 0.91
LUMiC(®) Endoprosthetic Reconstruction After Periacetabular Tumor Resection: Short-term Results. Clin Orthop Relat Res (2017) 0.88
Constrained total hip megaprosthesis for primary periacetabular tumors. Clin Orthop Relat Res (2013) 0.88
Use of silver in the prevention and treatment of infections: silver review. Surg Infect (Larchmt) (2013) 0.88
Evaluation of a reconstruction reverse shoulder for tumour surgery and tribological comparision with an anatomical shoulder arthroplasty. Int Orthop (2013) 0.86
Antimicrobial activity of thin solid films of silver doped hydroxyapatite prepared by sol-gel method. ScientificWorldJournal (2014) 0.85
Dermal argyria: Cutaneous manifestation of a megaprosthesis for distal femoral osteosarcoma. Indian J Orthop (2014) 0.85
Preventing Implant-Associated Infections by Silver Coating. Antimicrob Agents Chemother (2016) 0.85
In vitro antimicrobial properties of silver-polysaccharide coatings on porous fiber-reinforced composites for bone implants. J Mater Sci Mater Med (2013) 0.83
Antibacterial efficacy of ultrahigh molecular weight polyethylene with silver containing diamond-like surface layers. AMB Express (2015) 0.81
Acute and subacute toxicity in vivo of thermal-sprayed silver containing hydroxyapatite coating in rat tibia. Biomed Res Int (2014) 0.80
Antibacterial effect of copper-bearing titanium alloy (Ti-Cu) against Streptococcus mutans and Porphyromonas gingivalis. Sci Rep (2016) 0.80
Silver nanoparticles in dental biomaterials. Int J Biomater (2015) 0.80
Antibacterial abilities and biocompatibilities of Ti-Ag alloys with nanotubular coatings. Int J Nanomedicine (2016) 0.79
Improvement of the shoulder function after large segment resection of the proximal humerus with the use of an inverse tumour prosthesis. Int Orthop (2014) 0.78
Evaluation of osseous integration of PVD-silver-coated hip prostheses in a canine model. Biomed Res Int (2015) 0.78
Substituted hydroxyapatites with antibacterial properties. Biomed Res Int (2014) 0.78
Concentration ranges of antibacterial cations for showing the highest antibacterial efficacy but the least cytotoxicity against mammalian cells: implications for a new antibacterial mechanism. Chem Res Toxicol (2015) 0.78
Antibacterial efficacy of titanium-containing alloy with silver-nanoparticles enriched diamond-like carbon coatings. AMB Express (2015) 0.78
Treatment solutions are unclear for perimegaprosthetic infections. Clin Orthop Relat Res (2013) 0.77
Performance evaluation of nanoclay enriched anti-microbial hydrogels for biomedical applications. Heliyon (2016) 0.77
Surface silver-doping of biocompatible glasses to induce antibacterial properties. Part II: Plasma sprayed glass-coatings. J Mater Sci Mater Med (2008) 0.76
Titanium Surface Priming with Phase-Transited Lysozyme to Establish a Silver Nanoparticle-Loaded Chitosan/Hyaluronic Acid Antibacterial Multilayer via Layer-by-Layer Self-Assembly. PLoS One (2016) 0.76
Enrichment of anodic MgO layers with Ag nanoparticles for biomedical applications. J Mater Sci Mater Med (2008) 0.75
Periprosthetic joint infections in modular endoprostheses of the lower extremities: a retrospective observational study in 101 patients. Patient Saf Surg (2016) 0.75
Subcutaneous Reaction of Rat Tissues to Nanosilver Coated Gutta-Percha. Iran Endod J (2017) 0.75
Antibacterial potency of different deposition methods of silver and copper containing diamond-like carbon coated polyethylene. Biomater Res (2016) 0.75
Ti-Ag-Pd alloy with good mechanical properties and high potential for biological applications. Sci Rep (2016) 0.75
CORR Insights™: High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review. Clin Orthop Relat Res (2013) 0.75
Silver-Coated Hip Megaprosthesis in Oncological Limb Savage Surgery. Biomed Res Int (2016) 0.75
Effects of cathode design parameters on in vitro antimicrobial efficacy of electrically-activated silver-based iontophoretic system. J Mater Sci Mater Med (2015) 0.75
New TiAg composite coating for bone prosthesis engineering shows promising microvascular compatibility in the murine dorsal skinfold chamber model. J Mater Sci Mater Med (2015) 0.75
[New surgical treatment options for bone tumors]. Pathologe (2014) 0.75
Understanding Long-term Silver Release from Surface Modified Porous Titanium Implants. Acta Biomater (2017) 0.75
Silver-coated megaprostheses: review of the literature. Eur J Orthop Surg Traumatol (2017) 0.75
In vivo biocompatibility and pacing function study of silver ion-based antimicrobial surface technology applied to cardiac pacemakers. Open Heart (2017) 0.75
Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol (2002) 10.03
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene (2003) 7.90
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol (2003) 3.93
Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol (2008) 2.63
Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock. Crit Care Med (2010) 2.22
Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res (2006) 2.13
Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest (2002) 2.06
HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Clin Cancer Res (2006) 1.93
Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. Neoplasia (2004) 1.92
Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol (2003) 1.78
Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys (2003) 1.70
Silver-coated megaendoprostheses in a rabbit model--an analysis of the infection rate and toxicological side effects. Biomaterials (2004) 1.69
Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin Cancer Res (2009) 1.68
Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma. J Cancer Res Clin Oncol (2005) 1.59
Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol (2002) 1.56
Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol (2010) 1.54
Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept. Cell Prolif (2003) 1.52
Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation. Cancer Res (2005) 1.51
Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort. Genes Chromosomes Cancer (2010) 1.50
Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor-masked hypovolemia. Crit Care Med (2003) 1.46
Gender-dependent association of the GNAS1 T393C polymorphism with early aseptic loosening after total hip arthroplasty. J Orthop Res (2008) 1.44
Osteoid osteoma and osteoblastoma of the spine: experiences with 22 patients. Clin Orthop Relat Res (2002) 1.42
Patellar articular cartilage lesions: in vitro MR imaging evaluation after placement in gadopentetate dimeglumine solution. Radiology (2004) 1.41
Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts. Eur Spine J (2013) 1.41
The 3-layered ductal epithelium in gynecomastia. Am J Surg Pathol (2012) 1.40
Injuries and overuse syndromes in golf. Am J Sports Med (2003) 1.38
Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature. BMC Cancer (2008) 1.37
Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response. Clin Cancer Res (2006) 1.32
Ten simple rules for doing your best research, according to Hamming. PLoS Comput Biol (2007) 1.32
Giant cell tumors of the axial skeleton. Sarcoma (2012) 1.29
Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. Eur J Cancer (2007) 1.29
Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer (2006) 1.28
Treatment and outcome of giant cell tumors of the pelvis. Acta Orthop (2009) 1.28
En bloc spondylectomy in malignant tumors of the spine. Eur Spine J (2008) 1.27
Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group. Cancer (2002) 1.25
Grade I chondrosarcoma of bone: the Münster experience. J Cancer Res Clin Oncol (2008) 1.25
Treatment options for recurrent giant cell tumors of bone. J Cancer Res Clin Oncol (2008) 1.24
Rotationplasty--quality of life after 10 years in 22 patients. Acta Orthop Scand (2002) 1.21
Peer reviewers can meet journals' criteria for authorship. BMJ (2013) 1.20
Osteosarcoma: the COSS experience. Cancer Treat Res (2009) 1.18
Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur J Cancer (2008) 1.18
Molecular subtyping of male breast cancer by immunohistochemistry. Mod Pathol (2011) 1.17
Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med (2002) 1.16
First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer. J Pathol (2005) 1.15
Implantation of hemipelvic prosthesis after resection of sarcoma. Clin Orthop Relat Res (2002) 1.15
Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone. BMC Cancer (2010) 1.13
CGH and CD 44/MIB-1 immunohistochemistry are helpful to distinguish metastasized from nonmetastasized sporadic pheochromocytomas. Mod Pathol (2004) 1.13
HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Cancer (2005) 1.12
The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer (2010) 1.12
Distinct amplification of an untranslated regulatory sequence in the egfr gene contributes to early steps in breast cancer development. Cancer Res (2003) 1.11
Publication rate of abstracts presented at the Annual Congress of the Spine Society of Europe (years 2000-2003). Eur Spine J (2012) 1.08
Prognostic relevance of increased angiogenesis in osteosarcoma. Clin Cancer Res (2004) 1.07
Identification of novel diagnostic markers for choroid plexus tumors: a microarray-based approach. Am J Surg Pathol (2006) 1.07
Periosteal osteosarcoma--a European review of outcome. Eur J Cancer (2005) 1.07
Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review. Int J Radiat Oncol Biol Phys (2009) 1.07
Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer. Genes Chromosomes Cancer (2004) 1.06
Distal femur and proximal tibia replacement with megaprosthesis in revision knee arthroplasty: a limb-saving procedure. Knee Surg Sports Traumatol Arthrosc (2012) 1.05
Misinterpretation of cup anteversion in total hip arthroplasty using planar radiography. Arch Orthop Trauma Surg (2006) 1.05
Relative paucity of gross genetic alterations in myoepitheliomas and myoepithelial carcinomas of salivary glands. J Pathol (2002) 1.05
CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification. Breast Cancer Res Treat (2009) 1.05
Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane. BMC Res Notes (2010) 1.03
Giant cell tumor of the spine. Clin Orthop Relat Res (2002) 1.03
Hip transposition as a limb salvage procedure following the resection of periacetabular tumors. J Surg Oncol (2010) 1.03
Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma. Lab Invest (2004) 1.03
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype? Genes Chromosomes Cancer (2009) 1.02
Cytokine plasma levels: reliable predictors for radiation pneumonitis? PLoS One (2008) 1.02
Cervical range of motion and strength in 4,293 young male adults with chronic neck pain. Eur Spine J (2012) 1.01